Exploring the multifaceted impact of lanthanides on physiological pathways in human breast cancer cells

Yi-Ming Huang,Tsu-Yu Hsu,Ching-Yu Liu,Yu-Chen Hsieh,Kuan-Yun Lai,Ya-Wen Yang,Kai-Yin Lo
DOI: https://doi.org/10.1016/j.tox.2024.153731
IF: 4.571
2024-01-28
Toxicology
Abstract:Lanthanum (La) and cerium (Ce), rare earth elements with physical properties similar to calcium (Ca), are generally considered non-toxic when used appropriately. However, their ions possess anti-tumor capabilities. This investigation explores the potential applications and mechanisms of LaCl 3 or CeCl 3 treatment in triple-negative breast cancer (TNBC) cell lines. TNBC, characterized by the absence of estrogen receptor (ERα), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression, is prone to early metastasis and resistant to hormone therapy . Our results demonstrate that La/Ce treatment reduces cell growth, and when combined with cisplatin, it synergistically inhibits cell growth and the PI3K/AKT pathway. La and Ce induce oxidative stress by disrupting mitochondrial function, leading to protein oxidation. Additionally, they interfere with protein homeostasis and induce nucleolar stress. Furthermore, disturbance in F-actin web formation impairs cell migration. This study delves into the mechanism by which calcium-like elements La and Ce inhibit breast cancer cell growth, shedding light on their interference in mitochondrial function, protein homeostasis, and cytoskeleton assembly.
pharmacology & pharmacy,toxicology
What problem does this paper attempt to address?